- Home
- About
- Team
- Today's Market
- Premium
- Research it
- Outlook
- Portfolio
- Mobile
- Trust Equitymaster
- Help
- Free Reports
MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- S&P BSE 200
S&P BSE 200 Index 
(B200)
Here is the latest update and chart of S&P BSE 200 Index. For more details, see how the stocks in the S&P BSE 200 are performing today.
| Live BSE Quotes | Sep 21, 2018 (Close) | ||
|---|---|---|---|
| Price (Rs)4,766.31 | Open (Rs) 4,842.49 | High (Rs) 4,866.00 | Low (Rs) 4,615.13 |
| % Change-1.13 | Volume 123,286,396 | Value (Rs) 38,440,924,482 | 52-Week H/L 5,071.51 / 4,229.09 |
| Live NSE Quotes |
|---|
| Not listed |
| BSE Sensex | CNX Nifty |
- Charts
-
PERIOD - Advanced Charts new
- Charts by TradingView
S&P BSE 200 Index
The S&P BSE 200 Index was at 4,766.3 (down 1.1%).
Within the S&P BSE 200 Index, the top gainers were OIL INDIA LTD. (up 5.2%) and RAJESH EXPORTS (up 4.3%). On the other hand, DEWAN H.FIN. (down 42.4%) and YES BANK (down 28.7%) were among the top losers.
Meanwhile, the benchmark S&P BSE SENSEX was at 36,841.6 (down 0.8%).
The S&P BSE 200 index is down 4.2% over the last 30 days. And over the last 1 year, it has gained 7.4%.
|
| |
Today's Market
Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)
After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.
Related Views On News
Shriram Multicap Fund: Will It Multiply Your Wealth? (Outside View)
Sep 21, 2018PersonalFN explains if you should be investing in the NFO: Shriram Multicap Fund --will it multiply wealth for you.
The Kavanaugh Scandal: Another Deep State Distraction (Vivek Kaul's Diary)
Sep 21, 2018Bill connects the dots between the power struggle in the US Supreme Court and the state of American politics.
Are There Any Public Sector Companies Out There That Reward Shareholders? (Vivek Kaul's Diary)
Sep 21, 2018The one factor that can make PSU stocks a compelling story...
My First Pharma Stock Recommendation! (The 5 Minute Wrapup)
Sep 21, 2018This company has not only created a niche in the pharma space, it has done so profitably.
Oh Yes! This is the Best Trading Opportunity in Two Decades (Profit Hunter)
Sep 21, 2018Getting ready to buy stocks once this correction is over? This private sector bank should be on a profit hunter's radar.
More Views on NewsMost Popular
Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)
Sep 12, 2018Is the pharma sector poised for a comeback? Is the worst over? I believe so.
Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)
Sep 12, 2018Richa has discovered the single most profitable opportunity in the market - read on to discover more...
Are You Blindly Investing In Equities? Read This...(Outside View)
Sep 11, 2018PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.
Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)
Sep 12, 2018PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.
Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)
Sep 14, 2018Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.
MoreOTHER USEFUL LINKS
MARKET STATS
|
| |
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
FOLLOW
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.